Rchr
J-GLOBAL ID：201401047440910330
Update date: Aug. 13, 2024
Kato Koichi
カトウ コウイチ | Kato Koichi
Affiliation and department：
Homepage URL (1)：
http://kaken.nii.ac.jp/d/r/50382198.ja.html
Research field (1)：
Radiology
Research keywords (6)：
ミクログリア
, 炭素11
, アミノレブリン酸
, PETトレーサー
, アミノイソ酪酸
, 腫瘍画像診断
Research theme for competitive and other funds (13)：
- 2022 - 2027 Development of multivalent PET tracers for the early diagnosis of Alzheimer's disease
- 2022 - 2025 中脳辺縁ドパミン神経系の鎮痛機序とその可塑性に関する研究
- 2019 - 2022 Development of PET tracers for the imaging of microglial cells and their activities
- 2018 - 2021 A study to visualize chronic pain by cerebrospinal microglial imaging by the PET
- 2017 - 2019 Dvelopment of PET tracers for imaging of myelin changes
- 2016 - 2019 Design and synthesis of novel amino acid PET tracer
- 2015 - 2018 Development of PET probes targeting P2X7 receptor for imaging neuroinflammation
- 2015 - 2018 Investigation of the molecular mechanism of transiently elevated tumor uptake of PET tracers at early time points after X-ray radiation
- 2015 - 2018 Study on the establishment of myelin-specific PET imaging technology
- 2014 - 2017 The development of fluorescent-PET dual tracer for malignant gliomas
- 2012 - 2015 Development of new tumor PET probes: C-11-labeled aminoisobutyric acid and analogs
- 2011 - 2013 11C-labeling reactions promoted by quaternary ammnonium fluorides and their application for PET studies
- 1998 - 1998 プロスタサイクリン受容体の脳内生理機能解明のための分子プローブの設計と合成
Show all
Papers (55)：
-
沖田 恭治, 加藤 孝一, 重本 蓉子, 佐藤 典子, 松本 俊彦, 松田 博史. アデノシン2A受容体遮断薬による線条体ドパミンD2受容体に対する影響の評価 PETスキャンを含むプラセボ対照ランダム化二重盲検比較試験. 臨床薬理の進歩. 2022. 43. 109-115
-
Moto Nakaya, Noriko Sato, Hiroshi Matsuda, Norihide Maikusa, Yoko Shigemoto, Daichi Sone, Tensho Yamao, Masayo Ogawa, Yukio Kimura, Emiko Chiba, et al. Free water derived by multi-shell diffusion MRI reflects tau/neuroinflammatory pathology in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.). 2022. 8. 1. e12356
-
Kyoji Okita, Toshihiko Matsumoto, Daisuke Funada, Maki Murakami, Koichi Kato, Yoko Shigemoto, Noriko Sato, Hiroshi Matsuda. Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography. Frontiers in pharmacology. 2022. 13. 820447-820447
-
Kyoji Okita, Koichi Kato, Yoko Shigemoto, Noriko Sato, Toshihiko Matsumoto, Hiroshi Matsuda. Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography. Frontiers in Neuroscience. 2021. 15. 729153-729153
-
Yumi Shintani, Koichi Kato, Masashi Kawami, Mikihisa Takano, Takuya Kumamoto. Direct N1-Selective Alkylation of Hydantoins Using Potassium Bases. Chemical and Pharmaceutical Bulletin. 2021. 69. 4. 407-410
ｍore...
MISC (2)：
-
宿里 充穂, 加藤 孝一, 花川 隆. 【これからの臨床PET薬剤】 多発性硬化症のPET診断. PET Journal. 2015. 31. 32-34
-
宿里 充穗, 加藤 孝一, 山村 隆, 張 明栄, 花川 隆. 11C-DAC PETによる多発性硬化症モデルラットの脳内炎症イメージング. JSMI Report. 2014. 7. 2. 96-96
Professional career (1)：
Work history (3)：
- 2021/10 - 現在 National Center of Neurology and Psychiatry National Institute of Neuroscience, Ncnp
- 2020/11 - 2021/09 National Center of Neurology and Psychiatry
- 2011/04 - 2020/10 National Center of Neurology and Psychiatry
Association Membership(s) (1)：
Society of Radiopharmaceutical Sciences
